KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Receivables - Net: 2009-2025

Historic Receivables - Net for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $748.3 million.

  • Charles River Laboratories International's Receivables - Net fell 3.83% to $748.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $748.3 million, marking a year-over-year decrease of 3.83%. This contributed to the annual value of $739.2 million for FY2024, which is 8.30% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Receivables - Net stood at $748.3 million, which was down 4.12% from $780.4 million recorded in Q2 2025.
  • Charles River Laboratories International's Receivables - Net's 5-year high stood at $820.5 million during Q3 2023, with a 5-year trough of $617.8 million in Q1 2021.
  • Over the past 3 years, Charles River Laboratories International's median Receivables - Net value was $787.2 million (recorded in 2024), while the average stood at $788.1 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Receivables - Net climbed by 21.39% in 2021, and later dropped by 8.30% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Receivables - Net (Quarterly) stood at $650.1 million in 2021, then grew by 17.48% to $763.7 million in 2022, then grew by 5.56% to $806.1 million in 2023, then decreased by 8.30% to $739.2 million in 2024, then dropped by 3.83% to $748.3 million in 2025.
  • Its Receivables - Net was $748.3 million in Q3 2025, compared to $780.4 million in Q2 2025 and $772.9 million in Q1 2025.